Virtu Financial’s Cytosorbents Corp CTSO Stock Holding History

Virtu Financial’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27K	Buy	+71,508	New	+$37.8K	﹤0.01%	1310
2026 Q1	–	Sell	-10,780	Closed	-$7K	–	1743
2025 Q4	$7K	Buy	+10,780	New	+$8.29K	﹤0.01%	1532
2024 Q1	–	Sell	-20,215	Closed	-$22K	–	1524
2023 Q4	$22K	Buy	+20,215	New	+$30K	﹤0.01%	1307
2022 Q1	–	Sell	-10,898	Closed	-$46K	–	1595
2021 Q4	$46K	Buy	+10,898	New	+$61.1K	﹤0.01%	1363
2019 Q1	–	Sell	-11,379	Closed	-$92K	–	1472
2018 Q4	$92K	Buy	+11,379	New	+$113K	0.01%	1152
2018 Q2	–	Sell	-13,733	Closed	-$97K	–	2051
2018 Q1	$97K	Buy	+13,733	New	+$104K	0.01%	1583
2017 Q4	–	Sell	-54,358	Closed	-$337K	–	2439
2017 Q3	$337K	Buy	+54,358	New	+$277K	0.02%	1275

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial's CTSO Position: Q2 2026 in Review

Virtu Financial opened a new position in Cytosorbents Corp (CTSO) in Q2 2026: 71,508 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CTSO as recently as Q4 2025.

Virtu Financial first reported a position in CTSO in Q3 2017 and has held it in 7 quarters since. The position peaked at $337K in Q3 2017. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

Virtu Financial held 71,508 shares of Cytosorbents Corp worth $27K as of Q2 2026.
Cytosorbents Corp was a new Virtu Financial position in Q2 2026.
Cytosorbents Corp made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1310 holding.
Virtu Financial first reported a position in Cytosorbents Corp in Q3 2017 and has held it in 7 quarters since.
Virtu Financial's Cytosorbents Corp position peaked at $337K in Q3 2017.
51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.